Skip to main content
TMCI
NASDAQ Industrial Applications And Services

CEO John T. Treace Buys $375K in Open Market Stock Purchases

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.92
Mkt Cap
$179.698M
52W Low
$1.17
52W High
$7.78
52W Position info
150% above low
Off High info
62% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TMCI has more than doubled off its 52-week low of $1.17.

Summary

TREACE MEDICAL CONCEPTS, INC. CEO John T. Treace made open market purchases totaling $375,505 in company stock, signaling strong insider confidence following recent Q1 earnings.


Key Events · Ownership and Investor Activity · TMCI

  • CEO Makes Significant Open Market Purchase

    John T. Treace, who serves as CEO, Director, and a 10% Owner, acquired 153,763 shares of common stock through open market purchases.

  • Substantial Investment Value

    The total value of these purchases amounted to $375,505, representing a notable investment by a key insider.

  • Timing Post-Earnings

    The transactions occurred between May 12-14, 2026, immediately following the company's Q1 2026 earnings report on May 8th, which showed an EPS beat and slightly raised guidance despite a revenue decline.

  • Purchase Price Range

    Shares were acquired at prices ranging from $2.17 to $2.62, below the current stock price of $2.92.


Analysis · TMCI · Industrial Applications And Services

CEO John T. Treace's significant open market purchase of over $375,000 in company stock, occurring immediately after the Q1 2026 earnings report, signals strong insider confidence. This comes despite recent mixed financial results, including a Q1 revenue decline, but follows an EPS beat and a slight raise in full-year guidance. The CEO's decision to invest personal capital at these levels suggests a belief in the company's future prospects and potential undervaluation.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TMCI was trading at $2.92 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $179.7M. The 52-week trading range was $1.17 to $7.78. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TMCI - Latest Insights

TMCI
Sep 17, 2026, 5:16 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.69
Real-time Price: $4.45 info
Change: -$0.240 (-5%) info
Market Cap: $288.753M info
TMCI
Aug 08, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $4.45 info
Change: -$0.250 (-5%) info
Market Cap: $288.753M info
TMCI
Aug 07, 2026, 7:42 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.75
Real-time Price: $4.45 info
Change: -$0.300 (-6%) info
Market Cap: $288.753M info
TMCI
Aug 07, 2026, 7:12 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.75
Real-time Price: $4.45 info
Change: -$0.300 (-6%) info
Market Cap: $288.753M info
TMCI
Aug 07, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.75
Real-time Price: $4.45 info
Change: -$0.300 (-6%) info
Market Cap: $288.753M info